Back to Results
First PageMeta Content
Ofatumumab / B-cell chronic lymphocytic leukemia / Alemtuzumab / Chlorambucil / Genmab / CD20 / Leukemia / HBsAg / Hepatitis B / Medicine / Chemistry / Oncology


Microsoft Word - Arzerra Data Backgrounder_FINAL
Add to Reading List

Open Document

File Size: 115,71 KB

Share Result on Facebook

Company

GlaxoSmithKline / GSK / Genmab / Glaxosmithkline plc / /

Country

United States / /

Currency

cent / /

Event

FDA Phase / Business Partnership / /

IndustryTerm

research-based pharmaceutical / healthcare / /

MedicalCondition

arrhythmia / abdominal pain / hypertension / bronchospasm / cancer / fatal neutropaenic sepsis / flushing / disease / arthralgia / headache / HBV / liver failure / chronic lymphocytic leukemia / tumour / hepatitis B / acute coronary syndrome / tumour lysis syndrome / syncope / Leukaemia / pulmonary / virus infection / Progressive Multifocal Leukoencephalopathy / hepatic failure / urticaria / angioedema / bradycardia / anaphylactic reactions / Chronic Lymphocytic Leukaemia / HEPATITIS / rash / back pain / herpes simplex / respiratory tract infection / myocardial ischemia / syndrome / agranulocytosis / hypotension / /

Organization

National Cancer Institute / FDA / American Cancer Society / Independent Review Committee / /

Product

Arzerra / Arzerra® (ofatumumab) / Results1 / /

ProvinceOrState

Oregon / /

Technology

antibodies / /

URL

http /

SocialTag